Scotia Capital’s THERATECHNOLOGIES INC COM THER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,150
Closed -$10.8K 839
2022
Q4
$10.8K Hold
12,150
﹤0.01% 779
2022
Q3
$29K Hold
12,150
﹤0.01% 762
2022
Q2
$27K Sell
12,150
-1,727
-12% -$3.84K ﹤0.01% 793
2022
Q1
$34K Sell
13,877
-273
-2% -$669 ﹤0.01% 862
2021
Q4
$43K Buy
+14,150
New +$43K ﹤0.01% 856

Other funds holding THER

Scotia Capital's THER Position: Q1 2023 in Review

Scotia Capital sold out of THERATECHNOLOGIES INC COM (THER) in Q1 2023, closing a stake of 12,150 shares — an estimated $10.8K sold.

Scotia Capital first reported a position in THER in Q4 2021 and held it in 5 quarters. The position peaked at $43K in Q4 2021. 40 funds tracked by Wall St. Rank hold THER as of Q1 2023.

  • Scotia Capital reported no remaining THERATECHNOLOGIES INC COM position as of Q1 2023 after selling out during the quarter.
  • Scotia Capital sold 12,150 THERATECHNOLOGIES INC COM shares in Q1 2023, an estimated $10.8K.
  • Scotia Capital first reported a position in THERATECHNOLOGIES INC COM in Q4 2021 and held it in 5 quarters.
  • Scotia Capital's THERATECHNOLOGIES INC COM position peaked at $43K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q1 2023.

Based on Scotia Capital's 13F filing for Q1 2023, filed 11 May 2023.